Mirae Asset Global Etfs Holdings Ltd. Atea Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 44,142 shares of AVIR stock, worth $131,984. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,142
Previous 42,242
4.5%
Holding current value
$131,984
Previous $141,000
4.26%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AVIR
# of Institutions
112Shares Held
50.9MCall Options Held
7.6KPut Options Held
38.7K-
Black Rock Inc. New York, NY9.12MShares$27.3 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$22.7 Million15.83% of portfolio
-
Tang Capital Management LLC San Diego, CA4.79MShares$14.3 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.67MShares$14 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.34MShares$9.99 Million0.52% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $249M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...